Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals.
about
Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer DementiaProspective associations of plasma phospholipids and mild cognitive impairment/dementia among African Americans in the ARIC Neurocognitive Study.Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort.Metabolic network failures in Alzheimer's disease: A biochemical road map.Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress.Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products.Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease.Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study.Metabolic status of CSF distinguishes rats with tauopathy from controls.Early Effect of Amyloid β-Peptide on Hippocampal and Serum Metabolism in Rats Studied by an Integrated Method of NMR-Based Metabolomics and ANOVA-Simultaneous Component Analysis.Targeted metabolomics and medication classification data from participants in the ADNI1 cohort.Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analysesSerum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway.Body mass index and risk of dementia: Analysis of individual-level data from 1.3 million individuals.Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse".Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts.A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations.Alzheimer's Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk MarkersHigh-Throughput Direct Mass Spectrometry-Based Metabolomics to Characterize Metabolite Fingerprints Associated with Alzheimer's Disease Pathogenesis
P2860
Q33801596-8739BE58-E0F2-48B3-A63D-26F02AC78CFAQ37543795-1C4F03AB-EC35-4EFE-8385-3D4DC720FA0CQ38603323-B9C80B21-08BB-4271-9833-73A113B7CCAEQ38877855-72E20918-8A09-41DC-BCD3-4F485651A8C3Q38980003-B9862F02-8DCD-4089-9E15-0640FBC6CAC9Q39386254-E90A738A-9838-4AC6-AD9A-C32F28179519Q40444820-326DC4CC-081D-4CCB-9C89-1F17B6C3A79EQ41196957-E42B4294-868F-420E-A51A-B375C8B4DC32Q41690749-17A755AA-E988-4F8A-BE79-211DD2CE9EA5Q42323524-4227BC88-22FE-4703-BFA7-0C34BA8F6C7FQ42379364-6BF9FF7C-BAD1-496E-89FD-003E0DD2B241Q42655692-4BBFEB39-C946-4A0D-B3F6-C8D881FACF7EQ47165587-C17A3D27-55A4-47E9-AEEE-D47030C820FDQ47201004-DBBAC7AB-2E34-4702-BECC-16DAA27F6688Q47423721-C6264EF7-478F-42B2-AB71-6D6CDAFB778DQ47549112-9F62B33E-35D3-440B-B256-390E8C7FDDADQ47587631-8B898007-17B0-4E17-8024-8A5FA907DB4AQ48762558-7AEE56FC-980E-4CEA-90ED-05FB2EE19423Q49135523-8B25C941-7AE7-442A-81E4-7B1DFF0E6A77Q51760901-A91AA3CF-2AB5-4613-9BD0-432345721AB1Q51764769-1D5EFFBC-9EBA-4AFC-861F-4C12EE03B1CEQ52609763-5BB91B22-E9BA-489B-8EEB-F57FF37CE687Q58586046-6536039A-A8CA-4281-B04B-0C418D82B642Q58723601-B9E7B26E-B82B-4D7B-A345-7044B2A6496C
P2860
Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Blood metabolite markers of pr ...... cohorts of older individuals.
@en
Blood metabolite markers of pr ...... cohorts of older individuals.
@nl
type
label
Blood metabolite markers of pr ...... cohorts of older individuals.
@en
Blood metabolite markers of pr ...... cohorts of older individuals.
@nl
prefLabel
Blood metabolite markers of pr ...... cohorts of older individuals.
@en
Blood metabolite markers of pr ...... cohorts of older individuals.
@nl
P2093
P2860
P50
P1476
Blood metabolite markers of pr ...... cohorts of older individuals.
@en
P2093
Brittany Simpson
Carlos Riveros
Cristina Legido Quigley
Denise Sonntag
Judith Wahrheit
Michael Griswold
Palmi V Jonsson
Ramon Casanova
Santiago Saldana
P2860
P304
P356
10.1016/J.JALZ.2015.12.008
P50
P577
2016-01-21T00:00:00Z